GENZYME CORP Accounts Receivable
GENZYME CORP had Accounts Receivable of $1.09 billion as of 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2011-03-01
- 2010-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $1.09B.
- 2010-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $935.19M.
- 2010-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $890.24M.
- 2010-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $904.10M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2010-12-31 | $1.09B 10-K · filed 2011-03-01 |
| 2010-09-30 | $935.19M 10-Q · filed 2010-11-09 |
| 2010-06-30 | $890.24M 10-Q/A · filed 2010-09-07 |
| 2010-03-31 | $904.10M 10-Q/A · filed 2010-05-11 |
| 2009-12-31 | $899.73M 10-K · filed 2011-03-01 |
| 2009-09-30 | $993.21M 10-Q · filed 2009-11-02 |
| 2009-06-30 | $1.14B 10-Q/A · filed 2009-09-04 |
| 2008-12-31 | $1.04B 8-K · filed 2010-06-14 |